Associations between serum carotenoids and tocopherols and type-specific HPV persistence: The Ludwig-McGill cohort study

International Journal of Cancer

Volumn 120, Issue 3, 2007, Pages 672-680

  Siegel, Erin M ^a   Craft, Neal E ^b   Duarte Franco, Eliane ^c   Villa, Luisa L ^d   Franco, Eduardo L ^c   Giuliano, Anna R ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Craft Technologies Inc   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

Carotentoid; Human papillomavirus; Persistence; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CAROTENOID; DELTA TOCOPHEROL; RETINOL; TOCOPHEROL; TRACE ELEMENT;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; NUTRITIONAL STATUS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; WART VIRUS;

ADULT; ANTIOXIDANTS; CAROTENOIDS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; QUEBEC; TOCOPHEROLS; VITAMIN A;

EID: 33845710826     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22346     Document Type: Article

References (33)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl. 8):S4-S66.
2. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-14.
3. Hinchliffe SA, van Velzen D, Korporaal H, Kok PL, Boon ME. Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br J Cancer 1995;72:943-5.
4. Giuliano AR, Papenfuss M, Nour M, Canfield LM, Schneider A, Hatch K. Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 1997;6:917-23.
5. Giuliano AR, Gapstur S. Can cervical dysplasia and cancer be prevented with nutrients? Nutr Rev 1998;56:9-16.
6. Garcia-Closas R, Castellsague X, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 2005;117:629-37.
7. Castle PE, Giuliano AR. Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr 2003:29-34.
8. Giuliano AR. The role of nutrients in the prevention of cervical dysplasia and cancer. Nutrition 2000;16:570-3.
9. Sedjo RL, Roe DJ, Abrahamsen M, Harris RB, Craft N, Baldwin S, Giuliano AR. Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2002;11:876-84.
10. Giuliano AR, Siegel EM, Roe DJ, Ferreira S, Luiza Baggio M, Galan L, Duarte-Franco E, Villa LL, Rohan TE, Marshall JR, Franco EL. Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV natural history study. J Infect Dis 2003;188:1508-16.
11. Palan PR, Chang CJ, Mikhail MS, Ho GY, Basu J, Romney SL. Plasma concentrations of micronutrients during a nine-month clinical trial of β-carotene in women with precursor cervical cancer lesions. Nutr Cancer 1998;30:46-52.
12. Sedjo RL, Papenfuss MR, Craft NE, Giuliano AR. Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States). Cancer Causes Control 2003;14:319-26.
13. Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003;95:1336-43.
14. Cooney RV, Franke AA, Hankin JH, Custer LJ, Wilkens LR, Harwood PJ, Le Marchand L. Seasonal variations in plasma micronutrients and antioxidants. Cancer Epidemiol Biomarkers Prev 1995;4:207-15.
15. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil Ludwig-McGill study group. Rev Panam Salud Publica 1999;6:223-33.
16. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-7.
17. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manos MM. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
18. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Deluis H, Peyton CL, Bauer HM, Wheeler CM. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;170:1077-85.
19. Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997;6:487-91.
20. Britton G. Structure and properties of carotenoids in relation to function. FASEB J 1995;9:1551-8.
21. Willett WC. Nutritional epidemiology. 2nd edn. New York: Oxford University Press, 1998.
22. Diggle PJ, Liang K-Y, Zeger SL. Analysis of longitudinal data. 1st edn. Oxford: Oxford University Press, 1994.
23. Hardin J, Hilbe JM. Generalized estimating equationsed. Boca Raton, FL: Chapman & Hall, 2003.
24. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
25. Rousseau MC, Franco EL, Villa LL, Sobrinho JP, Termini L, Prado JM, Rohan TE. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer Epidemiol Biomarkers Prev 2000;9:469-76.
26. Schiffman M, Kjaer SK. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003:14-9.
27. Goodman MT, Hernandez B, McDuffie K, Franke A, Wilkens L. Effect of diet and serum micronutrients on clearance of cervical human papillomavirus. Presented at the 22nd International Papillomavirus Conference, 2005.
28. Goodman M, Cheung L, Hernandez B, McDuffie K, Wilkens L. Serum micronutrient concentrations and cervical human papillomavirus persistence. Presented at the 21st International Papillomavirus Conference, 2004.
29. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
30. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002;38:2229-42.
31. Tendler A, Ho GY, Kadish AS. Do "high-risk" human papillomavirus (HPV) types lead to cancer by evading the immune system? Gynecol Oncol 1999;73:169-70.
32. Beck MA. Antioxidants and viral infections: host immune response and viral pathogenicity. J Am Coll Nutr 2001;20:384S-388S: discussion 96S-97S.
33. Stahl W, Sies H. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys 1996;336:1-9.